Lineage Cell Therapeutics (LCTX) Construction in Progress (2016 - 2019)
Historic Construction in Progress for Lineage Cell Therapeutics (LCTX) over the last 6 years, with Q1 2019 value amounting to $8.9 million.
- Lineage Cell Therapeutics' Construction in Progress changed N/A to $8.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2018, which is 7708.3% down from last year.
- According to the latest figures from Q1 2019, Lineage Cell Therapeutics' Construction in Progress is $8.9 million.
- In the past 5 years, Lineage Cell Therapeutics' Construction in Progress ranged from a high of $8.9 million in Q1 2019 and a low of $93000.0 during Q4 2015
- Moreover, its 5-year median value for Construction in Progress was $1.6 million (2016), whereas its average is $3.1 million.
- Its Construction in Progress has fluctuated over the past 5 years, first crashed by 7709.36% in 2015, then skyrocketed by 11726.19% in 2016.
- Lineage Cell Therapeutics' Construction in Progress (Quarter) stood at $93000.0 in 2015, then skyrocketed by 1620.43% to $1.6 million in 2016, then skyrocketed by 245.81% to $5.5 million in 2017, then plummeted by 77.08% to $1.3 million in 2018, then soared by 603.31% to $8.9 million in 2019.
- Its Construction in Progress was $8.9 million in Q1 2019, compared to $1.3 million in Q4 2018 and $5.1 million in Q3 2018.